Mayo Clinic Upper Digestive Disease Survey

Abroad (travel likely)Recruiting

Conditions

Esophageal Neoplasms · Cancer of Esophagus · Cancer of the Esophagus · Esophageal Cancer · Esophagus Cancer · Neoplasm, Esophageal · Esophagectomy · Abnormalities, Digestive System · Digestive System Abnormalities

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Karlyn Pierson, MAN, RN) · pierson.karlyn@mayo.edu · 507-538-1960

Study leads

Luis Tapias Vargas, MD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Proton Therapy for Esophageal Cancer

Esophagus Cancer

Abroad (travel likely)Recruiting

Loma Linda, United States

A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring

Esophageal Cancer · ctDNA

Abroad (travel likely)Recruiting

Jinhua, China · Lishui, China

A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer

Esophageal Cancer

Abroad (travel likely)RecruitingPHASE2

Nanjing, China